International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection
Open Access
- 30 April 2004
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 127 (4) , 1126-1132
- https://doi.org/10.1016/j.jtcvs.2003.11.009
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Registry Of The International Society For Heart And Lung Transplantation: Nineteenth Official Report—2002The Journal of Heart and Lung Transplantation, 2002
- Obliterative bronchiolitis after lung transplantationCurrent Opinion in Pulmonary Medicine, 2000
- Bronchiolitis Obliterans: Pathogenesis, Prevention, and ManagementThe Lancet Healthy Longevity, 1998
- TACROLIMUS AS A RESCUE IMMUNOSUPPRESSANT AFTER HEART AND LUNG TRANSPLANTATION1Transplantation, 1998
- Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantationThe Annals of Thoracic Surgery, 1996
- A MULTICENTER TRIAL OF FK506 (TACROLIMUS) THERAPY IN REFRACTORY ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1996
- DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME IN RECIPIENTS OF HEART-LUNG TRANSPLANTATION-EARLY RISK FACTORSTransplantation, 1996
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1995
- A PROSPECTIVE RANDOMIZED TRIAL OF FK506 VERSUS CYCLOSPORINE AFTER HUMAN PULMONARY TRANSPLANTATION1Transplantation, 1994
- FK506 conversion for intractable rejection of the liver allograftTransplant International, 1993